Background Head-to-head comparisons of sodium–glucose cotransporter-2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors remain limited in East Asian populations. We compared outcomes in Korean adults with type 2 diabetes entering combination oral therapy.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ju
Contact Ju, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack